+19.7%
ABNB vs EMR
+62.0%
-42.3%
-37.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.1% | -0.4% | -3.6% | -3.9% |
| 7D | -4.4% | +3.1% | -7.4% | -5.7% |
| 30D | -2.0% | -3.5% | +1.6% | -0.5% |
| 3M | +29.8% | +9.8% | +20.1% | +23.2% |
| 6M | +31.0% | +10.8% | +20.2% | +22.7% |
| YTD | +28.6% | +15.9% | +12.7% | +16.3% |
| 1Y | +40.1% | +16.4% | +23.6% | +25.4% |
| 3Y | +19.7% | +62.1% | -42.4% | -9.7% |
| All | +19.7% | +62.0% | -42.3% | -9.7% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling